Mas Chaponda

884 total citations
21 papers, 554 citations indexed

About

Mas Chaponda is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Mas Chaponda has authored 21 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Mas Chaponda's work include HIV/AIDS Research and Interventions (6 papers), Pneumonia and Respiratory Infections (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Mas Chaponda is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), Pneumonia and Respiratory Infections (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Mas Chaponda collaborates with scholars based in United Kingdom, Malawi and Qatar. Mas Chaponda's co-authors include Munir Pirmohamed, Malcolm E. Molyneux, Stephen B. Gordon, Amanda Walsh, Robert C. Read, Melita A. Gordon, D. Soko, Saye Khoo, Richard Odame Phillips and Anna María Geretti and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Mas Chaponda

18 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mas Chaponda United Kingdom 12 323 156 101 85 84 21 554
Christer Lidman Sweden 16 510 1.6× 248 1.6× 33 0.3× 103 1.2× 20 0.2× 32 657
Xien Gui China 13 235 0.7× 361 2.3× 47 0.5× 77 0.9× 8 0.1× 46 618
Pierre de Truchis France 13 181 0.6× 259 1.7× 98 1.0× 21 0.2× 8 0.1× 50 644
George Perez United States 15 353 1.1× 413 2.6× 13 0.1× 70 0.8× 49 0.6× 36 785
Albert Dompreh Ghana 12 105 0.3× 201 1.3× 38 0.4× 24 0.3× 17 0.2× 35 367
Francisco Jover Spain 11 170 0.5× 91 0.6× 41 0.4× 70 0.8× 10 0.1× 43 442
Rodrigo de Carvalho Santana Brazil 12 139 0.4× 99 0.6× 10 0.1× 56 0.7× 33 0.4× 39 440
Aaron G. Lim United Kingdom 12 397 1.2× 89 0.6× 12 0.1× 284 3.3× 18 0.2× 49 644
Alma Muñoz United States 12 656 2.0× 113 0.7× 47 0.5× 23 0.3× 430 5.1× 18 786
Mario Cepparulo Italy 11 135 0.4× 53 0.3× 56 0.6× 67 0.8× 6 0.1× 22 373

Countries citing papers authored by Mas Chaponda

Since Specialization
Citations

This map shows the geographic impact of Mas Chaponda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mas Chaponda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mas Chaponda more than expected).

Fields of papers citing papers by Mas Chaponda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mas Chaponda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mas Chaponda. The network helps show where Mas Chaponda may publish in the future.

Co-authorship network of co-authors of Mas Chaponda

This figure shows the co-authorship network connecting the top 25 collaborators of Mas Chaponda. A scholar is included among the top collaborators of Mas Chaponda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mas Chaponda. Mas Chaponda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaponda, Mas, et al.. (2025). A Systematic Literature Review on Pre-exposure Prophylaxis as a Strategy for HIV Risk Reduction in the Middle East. Cureus. 17(3). e80842–e80842. 1 indexed citations
2.
Maslamani, Muna Al, Abdullatif Al‐Khal, Mas Chaponda, et al.. (2025). A Cluster of Meningococcal Serogroup W135 Infections: A Case Series. Cureus. 17(3). e80747–e80747.
3.
Chaponda, Mas, et al.. (2023). Investigating zero transmission of HIV in the MSM population: a UK modelling case study. Archives of Public Health. 81(1). 201–201. 1 indexed citations
4.
Chaponda, Mas, et al.. (2022). Elizabethkingia meningoseptica Infection in COVID-19 Patients. Cureus. 14(10). e30337–e30337. 1 indexed citations
5.
6.
Danjuma, Mohammed, et al.. (2022). Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis. Therapeutic Advances in Drug Safety. 13. 1571533019–1571533019. 11 indexed citations
7.
Bhole, Malini, Mas Chaponda, & Nicholas J. Beeching. (2018). Human immunodeficiency virus infection. Oxford University Press eBooks.
8.
Chaponda, Mas, et al.. (2018). Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK. International Journal of STD & AIDS. 29(7). 704–713. 35 indexed citations
9.
Lewis, Joseph M., Colette Smith, Shazaad Ahmad, et al.. (2017). Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study. Journal of Infection. 74(4). 401–407. 11 indexed citations
10.
Stockdale, Alexander, Mas Chaponda, Apostolos Beloukas, et al.. (2017). Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health. 5(10). e992–e1003. 89 indexed citations
11.
Lewis, Joseph M., et al.. (2016). Early experience of dolutegravir pharmacokinetics in pregnancy. AIDS. 30(8). 1313–1315. 12 indexed citations
12.
Carr, Daniel F., et al.. (2014). CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA‐C*04:01 in a Malawian HIV population. Clinical and Translational Allergy. 4(S3). 1 indexed citations
13.
Carr, Daniel F., Mas Chaponda, Andrea Jorgensen, et al.. (2013). Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population. Clinical Infectious Diseases. 56(9). 1330–1339. 78 indexed citations
14.
Kampira, Elizabeth, et al.. (2012). Pharmacogenetics Research Developments in Africa: A Focus on Malawi. Current pharmacogenomics and personalized medicine (Online). 10(1). 87–97. 2 indexed citations
15.
Carrol, Enitan D., Antony Payton, Deborah Payne, et al.. (2011). The IL1RN Promoter rs4251961 Correlates with IL-1 Receptor Antagonist Concentrations in Human Infection and Is Differentially Regulated by GATA-1. The Journal of Immunology. 186(4). 2329–2335. 31 indexed citations
16.
Chaponda, Mas & Munir Pirmohamed. (2010). Hypersensitivity reactions to HIV therapy. British Journal of Clinical Pharmacology. 71(5). 659–671. 62 indexed citations
17.
Gordon, Stephen B., Amanda Walsh, Mas Chaponda, et al.. (2003). Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi. Emerging infectious diseases. 9(6). 747–749. 36 indexed citations
18.
Gordon, Stephen B., Mas Chaponda, Amanda Walsh, et al.. (2002). Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS. 16(10). 1409–1417. 66 indexed citations
19.
Gordon, Stephen B., Malcolm E. Molyneux, Martin J. Boeree, et al.. (2001). Opsonic Phagocytosis ofStreptococcus pneumoniaeby Alveolar Macrophages Is Not Impaired in Human Immunodeficiency Virus–Infected Malawian Adults. The Journal of Infectious Diseases. 184(10). 1345–1349. 25 indexed citations
20.
Gordon, Stephen B., Amanda Walsh, Mas Chaponda, et al.. (2000). Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and Seasonal. Clinical Infectious Diseases. 31(1). 53–57. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christer Lidman Breakdown of academic impact, for papers by Xien Gui Breakdown of academic impact, for papers by Pierre de Truchis Breakdown of academic impact, for papers by George Perez Breakdown of academic impact, for papers by Albert Dompreh Breakdown of academic impact, for papers by Francisco Jover Breakdown of academic impact, for papers by Rodrigo de Carvalho Santana Breakdown of academic impact, for papers by Aaron G. Lim Breakdown of academic impact, for papers by Alma Muñoz Breakdown of academic impact, for papers by Mario Cepparulo
Rankless by CCL
2026